EXICURE, INC. Loss Contingency Accrual
EXICURE, INC. (XCUR) had Loss Contingency Accrual of $1.00 million as of 2025-07-29, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Commitment and Contingencies › Loss Contingency Accrual, Disclosures
us-gaap:LossContingencyAccrualAtCarryingValue · last filed 2026-08-14
- 2025-07-29: Loss Contingency Accrual $1.00M.
- 2024-09-30: Loss Contingency Accrual $1.10M; Loss Contingency Accrual as first filed $1.14M.
| Period end | Loss Contingency Accrual | Loss Contingency Accrual as first filed |
|---|---|---|
| 2025-07-29 | $1.00M 10-Q · filed 2026-08-14 | |
| 2024-09-30 | $1.10M 10-Q · filed 2026-08-14 | $1.14M 10-Q · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |